61 – 70 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
- Contribution to journal › Published meeting abstract
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
- Contribution to journal › Article
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- Contribution to journal › Article
- 2017
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
- Contribution to journal › Published meeting abstract
-
Mark
Frequent miRNA-convergent fusion gene events in breast cancer
- Contribution to journal › Article
-
Mark
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- Contribution to journal › Article
-
Mark
Myoepithelium assessment with p63 immunostaining in formalinfixed paraffin-embedded breast cancer tissue pre-treated with RNA-later
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
- Contribution to journal › Article
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
- Contribution to journal › Article
